Downloads
Abstract
Cancer is the second leading cause of death after cardiovascular disease. The etiology caused not only exogenous environmental factors, but also internal endogenous factors, especially genetic factors. Approximately 5 % of diagnosed cancer patients are involved in the presence of genetic variation. To date, more than 80 genes related to genetic factors have been identified. The family history has been identified as one of the most important factors in identifying cancer-related to genetic factors. In this review, we will retrieve the literature to highlight the role molecular biology in medical oncogenetic counseling, particularly in breast and ovarian cancer syndrome, and Lynch syndrome in colorectal cancer, endometrial cancer.
References
“Oncogénétique en 2016 - Consultations, laboratoires et suivi - Ref : ADONCOG17| Institut National Du Cancer.” [Online]. Available: http://www.e-cancer.fr/Expertises- et-publications/Catalogue-des-publications/ Oncogenetique-en-2016-Consultations- laboratoires-et-suivi. [Accessed: 30-Jul-2018].
H. Shimodaira, “[Molecular Targeted Therapies for Hereditary Cancer Syndrome],” Gan To Kagaku Ryoho, vol. 45, no. 4, pp. 587–592, Apr. 2018.
R. Agarwal et al., “Targeted therapy for hereditary cancer syndromes: hereditary breast and ovarian cancer syndrome, Lynch syndrome, familial adenomatous polyposis, and Li-Fraumeni syndrome,” Discov. Med., vol. 18, no. 101, pp. 331–339, Dec. 2014.
Y. H. and T. J, “Management of hereditary breast and ovarian cancer. - PubMed - NCBI.” [Online]. Available: https://www.ncbi.nlm.nih. gov/pubmed/29185095. [Accessed: 30-Jul- 2018].
J. M. Carethers and E. M. Stoffel, “Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer,” World J. Gastroenterol., vol. 21, no. 31, pp. 9253–9261, Aug. 2015.
A. S. Bruegl, A. Kernberg, and R. R. Broaddus, “Importance of PCR-based Tumor Testing in the Evaluation of Lynch Syndrome-associated Endometrial Cancer,” Adv. Anat. Pathol., vol. 24, no. 6, pp. 372–378, Nov. 2017.
J. Shia, “Evolving approach and clinical significance of detecting DNA mismatch repair deficiency in colorectal carcinoma,” Semin. Diagn. Pathol., vol. 32, no. 5, pp. 352–361, Sep. 2015.
| Published | 27-08-2018 | |
| Fulltext |
|
|
| Language |
|
|
| Issue | No. 50 (2018) | |
| Section | Review | |
| DOI | ||
| Keywords | hội chứng ung thư di truyền hereditary cancer syndromes |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2025 Journal of Clinical Medicine Hue Central Hospital